Vircell

"Yesterday at ESCMID 2026, we had the pleasure of taking part in the Innovation & Pipeline Theatre with a session focused on invasive aspergillosis diagnosis 🧪

It was a great opportunity to share published evidence around the Aspergillus Galactomannan Ag VIRCLIA® Monotest and to be part of the scientific conversation taking place these days in Munich.

Thank you to everyone who joined Vircell’s session. Events like this are always a valuable chance to exchange ideas, hear different perspectives, and keep learning together.

If you’d like to stop by our booth, remember that tomorrow is your last chance to meet us👋

"